VOLUME 63 2002 NUMBER 10
Issue to be mailed October 22, 2002
CME Pretest 853
CME Posttest 954
Brainstorms
854 Independent Actions on Fear Circuits May Lead to
Therapeutic Synergy for Anxiety When Combining Serotonergic and
GABAergic Agents. Stephen M. Stahl
[PDF]
Original Articles
856 The Effects of Novel Antipsychotics on Glucose and Lipid
Levels. Donna A. Wirshing, Jennifer A. Boyd, Laura R. Meng,
Jacob S. Ballon, Stephen R. Marder, and William C. Wirshing
[Abstract]
[PDF]
866 A Longitudinal View of Triggers and Thresholds of Suicidal
Behavior in Depression. [CME] Lukas Pezawas, Mara
Stamenkovic, Reinhold Jagsch, Sandra Ackerl, Christine Putz,
Barbara Stelzer, Rebecca R. Moffat, Shird Schindler, Harald
Aschauer, and Siegfried Kasper
[Abstract]
[PDF]
874 Sexual Function and Behavior in Social Phobia. Liron
Bodinger, Haggai Hermesh, Dov Aizenberg, Avi Valevski, Sofi
Marom, Roni Shiloh, Doron Gothelf, Zvi Zemishlany, and Abraham
Weizman
[Abstract]
[PDF]
880 Clozapine-Induced Fevers and 1-Year Clozapine
Discontinuation Rate. Joseph C. Tham and Ruth A. Dickson
[Abstract]
[PDF]
885 Risperidone, 2 mg/day vs. 4 mg/day, in First-Episode,
Acutely Psychotic Patients: Treatment Efficacy and Effects on
Fine Motor Functioning. Marco C. G. Merlo, Helene Hofer,
Walter Gekle, Gregor Berger, Joseph Ventura, Ingrid Panhuber,
Gabriela Latour, and Stephen R. Marder
[Abstract]
[PDF]
892 Prevalence of and Risk Factors for Medication Nonadherence
in Patients With Schizophrenia: A Comprehensive Review of Recent
Literature. [CME] Jonathan P. Lacro, Laura B.
Dunn, Christian R. Dolder, Susan G. Leckband, and Dilip V. Jeste
[Abstract]
[PDF]
910 Serum Bupropion Levels in 2 Breastfeeding Mother-Infant
Pairs. Susan W. Baab, Kathleen S. Peindl, Catherine M.
Piontek, and Katherine L. Wisner
[Abstract]
[PDF]
912 Personality Impairment in Male Pedophiles. Lisa J.
Cohen, Pamela G. McGeoch, Sniezyna Watras-Gans, Sara Acker, Olga
Poznansky, Ken Cullen, Yelena Itskovich, and Igor Galynker
[Abstract]
[PDF]
920 Differential Effects of Risperidone, Olanzapine,
Clozapine, and Conventional Antipsychotics on Type 2 Diabetes:
Findings From a Large Health Plan Database. Frank D.
Gianfrancesco, Amy L. Grogg, Ramy A. Mahmoud, Ruey-hua Wang, and
Henry A. Nasrallah
[Abstract]
[PDF]
931 Olanzapine in Refractory Schizophrenia After Failure of
Typical or Atypical Antipsychotic Treatment: An Open-Label Switch
Study. Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka,
Jeffrey A. Lieberman, Leslie Citrome, Brian Sheitman, Miranda
Chakos, and Joseph P. McEvoy
[Abstract]
[PDF]
936 Risk Factors for Falls During Treatment of Late-Life
Depression. Jin H. Joo, Eric J. Lenze, Benoit H. Mulsant, Amy
E. Begley, Elizabeth M. Weber, Jacqueline A. Stack, Sati
Mazumdar, Charles F. Reynolds III, and Bruce G. Pollock
[Abstract]
[PDF]
942 Is Response to Prophylactic Lithium a Familial Trait? Paul
Grof, Anne Duffy, Patrizia Cavazzoni, Eva Grof, Julie Garnham,
Marsha MacDougall, Claire O'Donovan, and Martin Alda
[Abstract]
[PDF]
Letters To the Editor
948 Severe Hypertriglyceridemia Associated With Olanzapine. Steven
C. Stoner, Beth M. Dubisar, Rintu Khan, and Cynthia D. Farrar
[PDF]
949 Nicotine-Induced Angiogenesis. Michael Alan Schwartz
[PDF]
- Reply by R. Douglas Shytle, Archie A. Silver, and Paul R. Sanberg
Book Reviews 951
NOW @ Psychiatrist.com 956
Information for Authors
see July 2002, pages 591-593 or our Web site at www.psychiatrist.com/author.htm